ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,095.74
0.82%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Olema Pharmaceuticals Inc (OLMA) Share Price

OLMA Olema Pharmaceuticals Inc

9.06
0.33 (3.78%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Olema Pharmaceuticals Inc NASDAQ:OLMA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.33 3.78 9.06 8.79 9.64 9.07 8.51 8.82 625,146 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -96.66M -1.7286 -5.24 506.59M
 Type  Size  Price  Time  Units 
 9 23 8.79 21:32:51 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore OLMA News
15/05/202412:06EDGAR2Form 8-K - Current report
15/05/202412:01GLOBEOlema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
08/05/202421:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202421:06EDGAR2Form 8-K - Current report
08/05/202421:02GLOBEOlema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
08/05/202412:02GLOBEOlema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
07/05/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for OLMA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Olema Pharmaceuticals Inc Articles